Powered by Data and AI - partnering with onground retailers, reaching from cities to the last village of India.

India is the pharmacy of the world. We manufacture medicines for over 195 countries and territories. And yet, every single day, millions of our own people cannot get the right medicine, at the right time, at the right price. This paradox is what drove us to build HealthX.

The Indian pharmaceutical and wellness distribution system is one of the most fragmented industries on the planet. With over 65,000 stockists and 800,000 retail pharmacies and no consolidated digital backbone, the result is a system full of gaps that patients fall through every day.

A typical pharmacy in India occupies just 150 to 500 square feet. With over 50,000 SKUs in the market, often multiple brands for the same molecule, no single store can carry adequate inventory. Filling one prescription can mean visiting three different pharmacies. For a working family in India, that is a half-day lost. For a chronically ill patient who needs to do this monthly, it becomes a reason to simply give up on treatment.

And the problem of fake medicines is not abstract. One in five medicines sold in India's major cities is estimated to be fraudulent, containing no active ingredient, an expired compound, or worse, something harmful. A system without traceability, without temperature-controlled logistics, without data, is a system that cannot be trusted.

We are building HealthX at a moment when every macroeconomic signal is pointing in the same direction.

India now has the world's second-largest diabetic population, nearly 101 million diagnosed and an estimated 212 million if undiagnosed cases are counted. That is one in four of the world's diabetics, living right here.

India is rapidly becoming the chronic disease capital of the world. Diabetes, hypertension, cardiac conditions, and obesity are no longer diseases of the elderly; they are afflicting people in their thirties and forties, in villages and cities alike. The population requiring sustained, long-term medical care is projected to exceed 400 million, larger than the entire population of the United States. This is not a crisis on the horizon. It is happening now.

At the same time, India's digital revolution is creating the infrastructure for a new kind of healthcare. Smartphone and UPI adoption have made digital commerce a reality for hundreds of millions of first-time users. People who once had no choice but to stand in line at a government hospital are now discovering that healthcare can come to them. The model, however, must be India-specific: purely digital does not work here. What works is a hybrid model, technology and inventory at the centre, and trusted last-mile human networks at the edge.

The wholesale distribution landscape is also at a tipping point. India has over 65,000 distributors, whereas developed nations operate with 5 to 10 large players. Consolidation is inevitable. AI-driven supply chain management, real-time inventory visibility, and compliance-grade warehousing, with temperature-controlled logistics, will define the winners. HealthX is being built for that future.

And as AI transforms healthcare delivery globally, it will need structured, digital-first health data to deliver on its promise of prediction and prevention. The ecosystem that captures that data, from prescriptions to adherence patterns to supply chain signals, will shape the next decade of Indian healthcare. We intend to build that ecosystem.